diagnostics.ai

London, United Kingdom  All United Kingdom companies → — Founded 2009
Point-of-Care Diagnostics Specialty-Focused AI
Infectious Disease Laboratory Medicine Pathology
Lab & Diagnostics
Later Stage VC
Website Claim this company

Products

PCR.AI
diagnostics.ai
Lab & Diagnostics
PCR.AI is an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data, using machine learning algorithms to interpret fluorescence curves and classify results.
Tiered pricing model, subscription-based for device manager, combination of deployment scope and implementation services for enterprise edition, partnership model for oem partners.

See all 1 product →

About diagnostics.ai

diagnostics.ai, formerly known as Azure PCR, is a UK-based healthcare AI company founded in 2009. Their core mission is to address patient safety issues stemming from problems in diagnostic testing by leveraging data science, artificial intelligence, and machine learning. The company develops automated PCR data analysis software, with their flagship product being pcr.ai. This platform automates data analysis in molecular diagnostics and research, aiming to provide instant diagnoses from blood or urine samples.

For physicians, diagnostics.ai’s technology offers several key benefits. The pcr.ai platform automates the widely-used qPCR method for infection testing, significantly reducing human error and improving reliability in laboratory operations. The AI Analysis Engine component of pcr.ai is CE-IVDR & MHRA registered as a Class A medical device software and has demonstrated over 99.9% interpretation accuracy in clinical validation studies. This enhanced accuracy and automation can lead to more precise patient treatment plans, improved patient safety, and reduced costs. The system also supports integration with laboratory information systems (LIMS/LIS) through various methods, including HL7, FHIR, REST APIs, and direct database connections, facilitating seamless workflow integration in clinical settings.

Focus Areas

AI-based automated diagnostics PCR data analysis machine learning in molecular diagnostics infection detection quality control in diagnostics laboratory automation

Business Intelligence

TechnologyAI-based learning machines, cloud-native (SOC 2 certified infrastructure), CE-IVDR certified AI Analysis Engine, API for integration with existing solutions

What Physicians Need to Know

AI-based Automated Diagnostics
diagnostics.ai specializes in AI-powered platforms that automate the analysis, quality control, and reporting of real-time PCR data. Their AI Analysis Engine has demonstrated >99.9% interpretation accuracy in clinical validation studies. This technology analyzes hundreds of data points per curve, identifying complex patterns and curve shapes, which significantly reduces false positives and handles high-noise environments, eliminating the need for manual configuration.
PCR Data Analysis
The company's PCR.AI platform uses advanced machine learning algorithms to interpret fluorescence curves, automatically classify results, apply quality control checks, and generate standardized reports. This approach is superior to traditional methods that rely on simple threshold crossing points, which are limited and error-prone. PCR.AI supports all major real-time PCR instruments, including Applied Biosystems, Bio-Rad, Qiagen, and Roche systems.
Machine Learning in Molecular Diagnostics
diagnostics.ai leverages machine learning to achieve unparalleled accuracy, availability, and automation in diagnostic laboratories. Their clinically-proven and certified technologies ensure high-quality results for routine testing. This includes advanced rules engines and QC, such as Westgard rules, for comprehensive analysis.
Infection Detection
By automating PCR data analysis and quality control, diagnostics.ai contributes to faster and more accurate infection detection. The system's ability to quickly and reliably interpret PCR results can significantly reduce turnaround times and improve the efficiency of infectious disease diagnostics.
Quality Control in Diagnostics
PCR.AI provides automated quality controls, complete audit trails, and standardized reporting, which are crucial for laboratory accreditation (e.g., ISO 15189, CAP, and CLIA requirements). The system automatically identifies and evaluates all standard control types, including positive, negative, extraction, and internal controls, applying appropriate quality checks and flagging failures based on laboratory-defined rules.
Laboratory Automation
diagnostics.ai offers solutions like the Integrated Workbench for end-to-end analysis and Device Manager to standardize tests and connect various sample-to-answer platforms. These tools streamline workflows, reduce hands-on time, and make data more accessible, ultimately leading to quicker results with lower costs and less risk of errors.
Physician Tip

For physicians, diagnostics.ai offers a significant advantage by providing highly accurate and automated diagnostic insights, particularly for PCR testing. The AI-powered analysis reduces the risk of human error and false positives, leading to more reliable results and supporting faster, more informed clinical decision-making. This allows physicians to focus more on patient care and complex cases, as routine analysis and data review are automated. The system's ability to integrate with existing LIMS/LIS systems ensures seamless data flow and comprehensive diagnostic insights, contributing to earlier disease detection and improved patient outcomes. While AI assists in diagnosis, it's important to remember it serves as a supportive 'second opinion' tool, augmenting clinical judgment rather than replacing it.

diagnostics.ai's PCR.AI platform is designed for flexible integration with laboratory information systems (LIMS/LIS) through various methods. The Enterprise Edition offers bidirectional integration capabilities supporting HL7, FHIR, REST APIs, and direct database connections. This ensures compatibility with existing laboratory infrastructure and facilitates a fully automated resulting process.

Products by diagnostics.ai

1 product in the directory

PCR.AI
diagnostics.ai
Lab & Diagnostics
PCR.AI is an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data, using machine learning algorithms to interpret fluorescence curves and classify results.
Tiered pricing model, subscription-based for device manager, combination of deployment scope and implementation services for enterprise edition, partnership model for oem partners.

Reviews & Opinions

No web reviews on file yet for diagnostics.ai. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about diagnostics.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for diagnostics.ai →

View all on YouTube

Press & Coverage

Tech Build Africa
AI Diagnostics funding: $5M Round (Oct 2026), raise history
AI Diagnostics raised $5 million in a funding round announced on October 2, 2026. This follows an undisclosed seed round on April 15, 2026.
2026-10
Daba Finance
SA-Based AI Diagnostics Raises $5.2M to Expand TB Screening Tech
AI Diagnostics secured ZAR85 million (approximately $5.2 million) to expand its tuberculosis screening platform across Africa and Asia. The funding will support clinical research, product development, and expansion, utilizing an AI model that analyzes lung sounds from a digital stethoscope.
2026-04
Business Wire
Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect
Diagnostics.ai launched the first CE-IVDR certified transparent AI platform for molecular diagnostics, demonstrating how AI-generated PCR result analyses are achieved. This platform addresses stringent EU regulations for diagnostic accuracy, reproducibility, and algorithm transparency.
2025-05
News-Medical
Diagnostics.ai launches fully-transparent machine learning platform for real-time PCR diagnostics
Diagnostics.ai introduced a fully-transparent machine learning platform for clinical real-time PCR diagnostics, providing clear explanations for AI-generated results. The platform aims to meet the heightened standards of the EU's In Vitro Diagnostic Medical Devices Regulation (IVDR).
2025-05
Becker's Hospital Review
AI in diagnostics: 10 findings healthcare leaders should know
The healthcare industry is advancing diagnostic AI beyond pilot stages, with new studies showing significant improvements in detecting various diseases. While AI models are achieving high accuracy, broader clinical reasoning and the role of AI as a physician-support tool remain key considerations.
2026-05
European Medical Journal
AI in Healthcare: Current and Future Applications in Diagnostics, Therapeutics, and Clinical Decision Making - European Medical Journal
AI is increasingly integrated into healthcare to address data complexity, workforce pressures, and the need for personalized diagnosis and treatment. This review highlights AI's role in enhancing clinical precision and efficiency, emphasizing the importance of integration into workflows, strong governance, and human-AI collaboration.
2026-06
Diagnostics World News
Regulatory Outlook in Diagnostics Innovative and Uncertain - Diagnostics World News
The diagnostics industry is experiencing significant clinical and technological changes, driven by AI and multi-biomarker tests, which are challenging existing regulatory systems. Debates are ongoing regarding the classification and reimbursement of algorithmic tests that use AI to interpret digital images.
2026-05
GOV.UK
AI Airlock: a regulatory sandbox for AI enabled Medical Devices - GOV.UK
The MHRA AI Airlock, a regulatory sandbox for AI-enabled Medical Devices, launched its third phase to address challenges in managing evolving AI applications, regulating AI-powered diagnostics, and implementing robust post-market surveillance. The program aims to inform a fit-for-purpose regulatory framework in Great Britain.
2026-10

Frequently Asked Questions

Diagnostics.ai leverages internationally patented AI-based learning machines that replicate the decision-making processes of expert clinical technicians. This technology, exemplified by their flagship product pcr.ai, automates routine analyses, eliminates manual steps in patient testing, and boasts an interpretation accuracy exceeding 99.9%, significantly reducing human error and improving reliability in infection detection.
Diagnostics.ai is dedicated to upholding high standards of quality, with its technology undergoing rigorous testing and receiving multiple certifications. Their AI Analysis Engine component within PCR.AI is CE-IVDR & MHRA registered as a Class A medical device software. They provide comprehensive documentation and support for laboratory accreditation (ISO 15189, CAP, CLIA) and continuously monitor evolving regulations.
Diagnostics.ai's primary product is pcr.ai, an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data. It supports all major real-time PCR instruments and works with most commercial and laboratory-developed assays. The system offers seamless LIMS integration, automatically exporting analyzed data to existing laboratory information management systems.
While specific pricing details for their Device Manager and Enterprise Edition vary by tier, OEM Partner pricing follows a flexible partnership model. Support options range from standard email support for Device Manager to priority phone support and dedicated Technical Account Managers for Enterprise Edition, with emergency support available across all tiers.
Diagnostics.ai, formerly Azure PCR, was founded in 2009, indicating over a decade of operation in the diagnostic testing space. They emphasize their commitment to quality, with their solutions being used daily by leading clinical labs globally. However, it is important to note that as of April 2026, Diagnostics.ai is an unfunded company.

Related Companies

AIRA Matrix
Thane, Maharashtra, India

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest

AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
Google DeepMind
London, United Kingdom, with research centers in the United States, Canada, France, Germany, and Switzerland. The London headquarters is located at Platform 37, Kings Cross Central.

Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Te
Tempus AI
Chicago, Illinois, U.S.

Tempus AI, Inc. is an American health technology company that utilizes data and artificial intelligence to deliver precision medicine services. The company was founded with the mission to bring data-driven precision medicine into routine care, initially focusing on oncology. Tempus has developed a platform that sequences tumor samples and employs AI models to assist physicians […]
LabLynx
Atlanta, Georgia, U.S. [1, 2, 3]

LabLynx is a privately held American laboratory informatics company that specializes in developing, supporting, and marketing Laboratory Information Management System (LIMS) solutions. The company has a long history in the industry, having introduced one of the first browser-based LIMS products in 1997. LabLynx’s primary offerings include ELab LIMS, a configurable cloud-based LIMS that serves various […]
August AI
Bengaluru, India

August AI is a healthcare artificial intelligence company that has developed an AI-powered digital health companion. This platform is designed to provide accessible medical care and health guidance, acting as a ‘health companion’ rather than a replacement for clinical visits. It assists users in understanding symptoms, interpreting medical reports, and managing ongoing treatment. The company’s […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.